$OWL

Blue Owl (NYSE: OWL) insider sells derivative tied to family trust's future gains

Blue Owl Co-President Marc Zahr transferred Blue Owl Operating Group Units to a family trust and sold a $14.9M derivative tied to future gains of these units, according to a Form 4 filing. The derivative agreement grants the trust rights to future appreciation above a $100K hurdle on specified Blue Owl interests, with settlement in 2033 or upon Zahr's death. Zahr disclaims beneficial ownership of the trust's securities except for pecuniary interest.

Original reporting
Published Sep 15, 2026, 12:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 5:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$OWL
Neutral
high confidence
Mentioned
$OWL
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$OWLNeutralLow
01

Why it matters

The filing is a routine disclosure with no change in beneficial ownership, offering little new information for traders.

02

Market read

The news is a low‑impact insider filing with minimal trading relevance.

03

What to watch

The $100,000 hurdle and long settlement date (2033) mean the payout is far in the future, limiting immediate relevance.

Relevance 4/10Novelty 4/10Timing: post filing

Background

Blue Owl Capital Inc. filed a Form 4 on September 14, 2026 showing a derivative transaction by its Co‑President for estate‑planning purposes.

Company-level read

Ticker impact

$OWLNeutralHigh confidence
Context

SEC Form 4 disclosed Co‑President Marc Zahr sold a $14.9M estate‑planning derivative tied to Blue Owl units.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

The transaction is a disclosed estate‑planning move with no immediate cash flow or ownership change, typical of routine insider filings.

Market effects

None; the filing is specific to Blue Owl and does not affect the broader asset‑management sector.

None; the news is company‑specific and limited to US investors.

Low; only relevant to shareholders of OWL.

Counterpoint

If the derivative reflects confidence in future appreciation, some investors may view it as a subtle bullish signal.

Key entities

  • Marc Zahr

    Co‑President and director of Blue Owl Capital Inc.

  • Zahr Family Gift Trust

    Family trust receiving the derivative contract.

Related articles

$ORCLHighAI 8/10

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge due to layoffs, potentially impacting its stock. Blue Owl (OWL) saw a 10.81% drop in stock value, closing at $10.56, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J’s (JNJ) orthopedics unit, with mixed performance in the medical devices sector.

$ORCLHighAI 9/10

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge, potentially impacting shares. Blue Owl (OWL) underperformed, losing 10.81%, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J's (JNJ) orthopedics unit, while Stryker (SYK) and Medtronic (MDT) show mixed performance.

$OWLMed

Blue Owl latest entrant into data center REIT race

Blue Owl Capital plans to form and IPO a data center REIT, seeded with a $6.5B portfolio. The company aims to raise funds for further acquisitions. Its shares rose over 1% on the news but are down 21% this year. Blue Owl manages $319B in assets, including Stack Infrastructure, and recently acquired Sila Realty Trust for $2.4B. The company also invested $3B in Meta's Hyperion data center project.

$OWLMed

Blue Owl’s Loparex Slips Toward Bankruptcy After Failed Deal

Blue Owl Capital marked down loans tied to Loparex from $122.43M to $8.34M after a failed merger, pushing Loparex into forbearance. Loparex's second lien debt fell over 94%. Loparex represented less than 1% of OBDC's portfolio, but investor nerves persist due to valuation uncertainties in private credit.

$IRENHighAI 9/10

Blue Owl leads $2.4 billion IREN GPU financing at 9%

Blue Owl Capital (NYSE: OWL) led a $2.4 billion financing for IREN (NASDAQ: IREN) to purchase NVIDIA GPUs for its Mackenzie campus. The deal includes a $1.2 billion term loan and $1.2 billion in notes, both at 9% interest. IREN plans to use the funds for AI infrastructure expansion, with proceeds drawn as hardware is delivered.